Science and Politics: FDA Perspective

Thursday, April 12, 2007, 12:15 p.m. - 1:30 p.m. Central Time

Coffman Memorial Union Theater

Event Description

This lecture described the role of science in federal agency policymaking and controversies that have arisen in the FDA, such as the debate surrounding medical devices recalls.

Continuing Legal Education (CLE), Continuing Medical Education (CME) and Continuing Nursing Education (CNE) credits were approved.

Speaker Biography

Scott Gottlieb, MD, is the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration and a former senior official at the Centers for Medicare and Medicaid Services.

At the FDA, Dr. Gottlieb is a senior advisor to Acting Commissioner, Dr. Andrew von Eschenbach, on all major agency matters including regulations, policy and administrative programs. His office works with all of the FDA’s centers on implementing and coordinating the agency’s regulatory and administrative policies aimed at advancing the public health.

From 2003-2004, Dr. Gottlieb served as a senior advisor to the FDA Commissioner and as the Agency’s Director of Medical Policy Development, leaving in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a Senior Adviser to the Administrator of Medicare and Medicaid Services.

Dr. Gottlieb’s research focuses on health policy, medical technology, and on seeking improvements in the public’s health through innovation in technology, medical practice, and healthcare delivery. He received his MD from the Mount Sinai School of Medicine.